Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
73 hedge funds and large institutions have $88.1M invested in Neos Therapeutics, Inc in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 13 closing their positions.
53% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 19
5% less funds holding
Funds holding: 77 → 73 (-4)
31% less capital invested
Capital invested by funds: $127M → $88.1M (-$39M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $398K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
+$3.57M |
| 2 |
NC
Nexthera Capital
New York
|
+$2.83M |
| 3 |
BlackRock
New York
|
+$1.9M |
| 4 |
Millennium Management
New York
|
+$802K |
| 5 |
JP Morgan Chase
New York
|
+$722K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$5.13M |
| 2 |
DM
Deerfield Management
New York
|
-$4.71M |
| 3 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$3.09M |
| 4 |
DA
DSC Advisors
Chicago,
Illinois
|
-$2.74M |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$2.68M |
NEOS Hedge Fund Activity: Q2 2018 in Review
73 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q2 2018, worth a combined $88.1M — down 31% from $127M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NEOS and 9 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 29 added.
The largest buyer was J. Goldman & Co, adding an estimated $3.57M. The largest seller was Cortina Asset Management, exiting entirely with an estimated $5.13M sold.
- 73 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q2 2018, down from 77 in Q1 2018.
- Funds reported $88.1M of Neos Therapeutics, Inc stock for Q2 2018, down 31% quarter-over-quarter.
- 9 funds opened new Neos Therapeutics, Inc positions in Q2 2018 and 13 closed out, a net change of -4 holders.
- The largest Neos Therapeutics, Inc buyer in Q2 2018 was J. Goldman & Co, an estimated $3.57M added.
- The largest Neos Therapeutics, Inc seller in Q2 2018 was Cortina Asset Management, an estimated $5.13M sold.
Based on aggregated 13F filings for Q2 2018.